“showed a trend”

All four analyzed symptoms showed a trend of declining by the end of therapy (36 months), but the percentage of patients reporting side effects remained higher compared to baseline values.

However, it showed a trend towards overestimation of risk for women at higher risk of sPTB, whereas our results show, in general, an underestimation of risk for patients with higher risk estimates.

Cannabinoids, particularly those administered via oromucosal spray and inhalation, generally showed a trend of effective pain reduction.

The additive effect of SP600125 treatment showed a trend, but was not statistically significant.

In China, in 1990, in terms of the incidence, prevalence, mortality rate, and DALYs of diabetes, all showed a trend of reaching a peak in the middle and old age stages with the increase of age.

Clinically, higher PC2 scores were associated with earlier onset of motor symptoms and showed a trend toward faster motor progression, while no significant association was observed with cognitive decline.

As the thickness increases, the adaptive frequency bands showed a trend of moving towards low frequencies(Fig. 3G ) 22 .

The specific ectoine content per unit biomass ( p ectoine ) showed a trend of initial stability followed by a significant increase with rising D.

Additionally, the KO group showed a trend toward lower proportions of monocytes and MHCII + macrophages compared with the WT macrophage-injected group, although these differences were not statistically significant ( Figure 2D ).

Results Soluble levels of PD-L2 were decreased in female PAD patients, whereas soluble levels of TIM-3 showed a trend towards an increased concentration in female PAD patients.

Although IgA + B220 + B cells showed a trend towards reduction in naïve Bank1 -/- SILP, it did not reach significance ( Figure 3A right).

6 F), showed a trend toward higher expression of the mesoderm marker Brachyury(T), the cardiac progenitor marker NKX2.5, and the cardiac marker TNNT2 in mRNA expression at day 12 of differentiation induction (Fig. 6 B).

OVCAR8 and OVCAR4 showed a trend for reducing gel sizes over 8 days, whereas OVCAR4 models showed no change, irrespective of LPA treatment.

During follow-up, both groups showed a trend toward higher LVEF and GLS, but the H-cTnI group demonstrated slower recovery in GLS, resulting in significantly lower GLS compared to the N-cTnI group.

In contrast, while younger individuals, males, and APOE4 carriers showed a trend toward improved AUC and model fit, these changes did not reach statistical significance.

Patients with positive PD-L1 expression, treated with ICIs at fewer than third line or combined with anti-angiogenic therapy showed a trend of higher DCR although without significance.

Basal insulin and HOMA-IR showed a trend toward higher values, although these differences were not statistically significant.

In contrast, lycopene showed a trend toward higher risk in the higher intake group among Non-Hispanic Black (OR = 4.99), which is highly consistent with the high prevalence of diabetic nephropathy among African-Americans as characterized by the U.

Results showed a trend of reduction in pain and stiffness and improvement in physical functioning.

R 2 values of the four sections studied showed a trend of inverse correlation with the effective fiber diameter ( Fig. 7d ).

Analysis of luciferase activity showed a trend towards decreased luminescence in Gpr4 −/− mice (Fig. 1B ).

No significant difference was observed in CD3 + CD8‐FOXP3+ lymphocytes between pre‐ and post‐NAC samples, even though this subpopulation showed a trend towards an increase in the stromal area in post‐NAC across all subtypes (Fig. 6D–F ).

However, in ICI-treated patients, high BTLA RNA levels corelated with longer PFS and OS in univariable analysis and showed a trend for OS in multivariable analysis.

recently reported that IVL in patients with ACS achieved similar angiographic success rates but showed a trend toward higher 30-day MACE compared with patients with stable angina. 25 In this study, the procedure success rate in the IVL group was as high as 87.5% despite the presence of calcified lesions presenting with ACS.

In our study, although the adequate dose group showed a trend toward a higher relapse rate compared to the higher dose group, the inferior OS observed in the higher dose group suggests that any potential reduction in relapse may have been offset by an increase in NRM.